Kit for assisting in determining degree of risk of emergence of psychotic symptoms of methamphetamine user

Abstract

The present invention discloses a kit for assisting in determining the degree of the risk of the emergence of psychotic symptoms of a methamphetamine user. The kit comprises a parameter acquisition scale and a readable carrier; and the parameter acquisition scale comprises scales for acquiring various parameters involved in the readable carrier; the readable carrier records the content of a formula I that y=0.149xseverity+0.018xCTQ+0.079xADHD 0.034xSSS, wherein xseverity indicates the scores of the severity of addiction to methamphetamine, xCTQ indicates the total scores of childhood trauma experience, xADHD indicates the total scores of the ADHD (attention deficit hyperactivity disorder) during primary school, xSSS indicates the total scores of the social support degree of a subject, andy indicates the risk of the emergence of the psychotic symptoms of the subject, wherein the subject is 18 to 60 years old. According to the kit of the invention, if the value of y is 0, it is indicated that the mental health of the subject is normal; if the value of y ranges from 0 to 1, it is indicated that the greater the value of y is, the greater the risk of the emergence of the psychotic symptoms of the subject is. The kit of the invention is easy to use. With the kit adopted, a scientific basis can be provided for a relationship between addiction to medicines and mental illness, and early warning can be performed for patients addicted to medicines.

Description

technical field [0001] The invention relates to a kit for assisting in judging the risk degree of mental symptoms of methamphetamine users, which belongs to the field of biomedicine. Background technique [0002] Substance addiction is a chronic relapsing encephalopathy characterized by compulsive drug use, persistent craving states, and diminished control over drug craving. In particular, the abuse of synthetic drugs such as "ice" (methamphetamine) has shown a rapid growth trend in recent years. Psychoactive substances such as methamphetamine have strong neuropsychotoxic effects. Long-term use can cause damage to the axons and nerve endings of dopaminergic neurons in the striatum, and even degeneration of nerve fibers, as well as damage to the neocortex and hippocampus of the brain. In addition, it can cause toxicity to tissues and organs such as the heart, liver, lungs, kidneys and skeletal muscles. [0003] Compared with traditional drugs, methamphetamine is more likely...

AI Technical Summary

Problems solved by technology

[0005] In summary, the mental symptoms of addicts are diverse, and the mechanism of comorbid addictive behaviors in adulthood caused by childhood trauma and childhood psychosis is complex, involving genetics, neurophysiological and psychological development, personality formation and deviation, and The interaction of social and environmental factors has not been fully elucidated so far, and there is no systematic method for early identification of methamphetamine users who are at risk of developing mental symptoms in the future

Images